In a representation to the Department of Pharmaceuticals, the group urges the government to replace Medanta chairman with a member free of potential conflicts of interest.
In a representation to the Department of Pharmaceuticals, the group urges the government to replace Medanta chairman with a member free of potential conflicts of interest.
<iframe src="https://hindustansphere.com/embed/cluster/5c0c868fabb0cb5908af32ba97427df58455ecec" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Advocacy group questions Medanta MD Naresh Trehan’s inclusion in panel on pharma marketing practices"></iframe>
In a representation to the Department of Pharmaceuticals, the group urges the government to replace Medanta chairman with a member free of potential conflicts of interest.
In a representation to the Department of Pharmaceuticals, the group urges the government to replace Medanta chairman with a member free of potential conflicts of interest.
